{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:10:51Z","timestamp":1777554651710,"version":"3.51.4"},"reference-count":43,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatitis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1097\/der.0000000000000894","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T11:03:42Z","timestamp":1651143822000},"page":"220-226","source":"Crossref","is-referenced-by-count":6,"title":["Establishing Consensus on the Treatment of Toxicodendron Dermatitis"],"prefix":"10.1177","volume":"33","author":[{"given":"Melissa","family":"Butt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"issue":"3","key":"bib1-20220520","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/DER.0000000000000472","article-title":"Poison ivy, oak, and sumac dermatitis: what is known and what is new?","volume":"30","year":"2019","journal-title":"Dermatitis"},{"issue":"1","key":"bib2-20220520","first-page":"34","article-title":"Poison ivy dermatitis","volume":"46","year":"1990","journal-title":"Cutis"},{"issue":"4","key":"bib3-20220520","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/bjd.19130","article-title":"Cost and diagnostic characteristics of Toxicodendron dermatitis in the USA: a retrospective cross-sectional analysis","volume":"183","year":"2020","journal-title":"Br J Dermato"},{"issue":"7","key":"bib4-20220520","first-page":"3","article-title":"Treatment of Toxicodendron dermatitis (poison ivy and poison oak)","volume":"6","year":"2001","journal-title":"Skin Therapy Lett"},{"issue":"9","key":"bib5-20220520","first-page":"482","article-title":"Treatment of Rhus dermatitis with non-prescription products","volume":"27","year":"1972","journal-title":"J Am Med Womens Assoc (1972)"},{"issue":"11","key":"bib6-20220520","first-page":"801","article-title":"Poison ivy: how effective are available treatments?","volume":"65","year":"2016","journal-title":"J Fam Pract"},{"issue":"6","key":"bib7-20220520","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.NAJ.0000377690.87350.36","article-title":"Emergency: treating poison ivy, oak, and sumac","volume":"110","year":"2010","journal-title":"Am J Nurs"},{"issue":"12","key":"bib8-20220520","first-page":"6","article-title":"Treating poisonous plants' rash of symptoms","volume":"10","year":"2003","journal-title":"Harv Womens Health Watch"},{"issue":"3","key":"bib9-20220520","first-page":"300","article-title":"Oral corticosteroids for poison ivy dermatitis","volume":"166","year":"2002","journal-title":"CMAJ"},{"issue":"4","key":"bib10-20220520","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0733-8627(20)30966-4","article-title":"Dermatitis","volume":"3","year":"1985","journal-title":"Emerg Med Clin North Am"},{"issue":"1","key":"bib11-20220520","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3810\/pgm.1999.07.614","article-title":"Taking the itch out of poison ivy. Are you prescribing the right medication?","volume":"106","year":"1999","journal-title":"Postgrad Med"},{"issue":"4","key":"bib12-20220520","first-page":"24","article-title":"An update on plant-related contact dermatitis","volume":"43","year":"1993","journal-title":"J Pract Nurs"},{"issue":"5","key":"bib13-20220520","first-page":"18","article-title":"What methods are effective to prevent or treat poison ivy\/oak\/sumac?","volume":"NS33","year":"1993","journal-title":"Am Pharm"},{"issue":"7","key":"bib14-20220520","first-page":"13","article-title":"Identification and treatment of poison ivy dermatitis","volume":"8","year":"1983","journal-title":"Nurse Pract"},{"issue":"2","key":"bib15-20220520","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1580\/PR31-05.1","article-title":"Toxicodendron dermatitis: poison ivy, oak, and sumac","volume":"17","year":"2006","journal-title":"Wilderness Environ Med"},{"issue":"1","key":"bib16-20220520","first-page":"62","article-title":"Poison ivy (Rhus) dermatitis","volume":"6","year":"1972","journal-title":"Am Fam Physician"},{"issue":"2","key":"bib17-20220520","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0738-081X(86)90080-5","article-title":"Poison-ivy and poison-oak dermatitis","volume":"4","year":"1986","journal-title":"Clin Dermatol"},{"issue":"2","key":"bib18-20220520","first-page":"166","article-title":"What is the best duration of steroid therapy for contact dermatitis (Rhus)?","volume":"55","year":"2006","journal-title":"J Fam Pract"},{"issue":"5\u20136","key":"bib19-20220520","first-page":"354","article-title":"Poison ivy, oak, and sumac dermatitis","volume":"171","year":"1999","journal-title":"West J Med"},{"issue":"6","key":"bib20-20220520","first-page":"429","article-title":"Treatment of severe poison ivy: a randomized, controlled trial of long versus short course oral prednisone","volume":"6","year":"2014","journal-title":"J Clin Med Res"},{"issue":"2","key":"bib21-20220520","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archfami.3.2.184","article-title":"Poison ivy dermatitis. Nuances in treatment","volume":"3","year":"1994","journal-title":"Arch Fam Med"},{"issue":"4","key":"bib22-20220520","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/00325481.1990.11704608","article-title":"Acute allergic contact dermatitis. How to manage severe cases","volume":"87","year":"1990","journal-title":"Postgrad Med"},{"issue":"1451","key":"bib23-20220520","first-page":"82","article-title":"Dermatitis due to Toxicodendron plants: a common occurrence during autumn","volume":"130","year":"2017","journal-title":"N Z Med J"},{"issue":"1","key":"bib24-20220520","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/pde.14408","article-title":"Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents","volume":"38","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"bib25-20220520","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaad.2020.12.058","article-title":"National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: version 2\u2014advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments","volume":"84","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"bib26-20220520","doi-asserted-by":"crossref","first-page":"adv00402","DOI":"10.2340\/00015555-3751","article-title":"Treat-to-target in atopic dermatitis: an international consensus on a set of core decision points for systemic therapies","volume":"101","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"bib27-20220520","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","year":"2001","journal-title":"Exp Dermatol"},{"key":"bib28-20220520","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bjd.19565","article-title":"Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment","volume":"184","year":"2021","journal-title":"Br J Dermatol"},{"issue":"suppl 2","key":"bib29-20220520","first-page":"10","article-title":"What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature","volume":"24","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"bib30-20220520","first-page":"763","article-title":"Outcome measures of disease severity in atopic eczema","volume":"136","year":"2000","journal-title":"Arch Dermatol"},{"issue":"3","key":"bib31-20220520","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"bib32-20220520","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","article-title":"Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases","volume":"133","year":"1997","journal-title":"Arch Dermatol"},{"issue":"5","key":"bib33-20220520","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","year":"1996","journal-title":"J Invest Dermatol"},{"issue":"2","key":"bib34-20220520","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/120347540100500202","article-title":"Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases","volume":"5","year":"2001","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"bib35-20220520","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00540020","article-title":"Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials","volume":"5","year":"1996","journal-title":"Qual Life Res"},{"issue":"5","key":"bib36-20220520","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2230.2001.00839.x","article-title":"Health-related quality of life among patients with facial acne\u2014assessment of a new acne-specific questionnaire","volume":"26","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"bib37-20220520","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bjd.18692","article-title":"The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials","volume":"183","year":"2020","journal-title":"Br J Dermatol"},{"issue":"12","key":"bib38-20220520","first-page":"1513","article-title":"The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective","volume":"140","year":"2004","journal-title":"Arch Dermatol"},{"issue":"5","key":"bib39-20220520","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/09546634.2012.742950","article-title":"Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity","volume":"24","year":"2013","journal-title":"J Dermatolog Treat"},{"issue":"10","key":"bib40-20220520","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.1991.03470100054031","article-title":"Failure of a tapering dose of oral methylprednisolone to treat reactions to poison ivy","volume":"266","year":"1991","journal-title":"JAMA"},{"issue":"2","key":"bib41-20220520","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s00464-019-06894-9","article-title":"The hidden cost of an extensive preoperative work-up: predictors of attrition after referral for bariatric surgery in a universal healthcare system","volume":"34","year":"2020","journal-title":"Surg Endosc"},{"issue":"6","key":"bib42-20220520","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.NURSE.0000446629.40220.38","article-title":"Poison ivy","volume":"44","year":"2014","journal-title":"Nursing"},{"issue":"5","key":"bib43-20220520","first-page":"845","article-title":"A systematic review of contact dermatitis treatment and prevention","volume":"53","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DER.0000000000000894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:06:19Z","timestamp":1777399579000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000894","relation":{},"ISSN":["2162-5220","1710-3568"],"issn-type":[{"value":"2162-5220","type":"electronic"},{"value":"1710-3568","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,28]]}}}